✦ LIBER ✦

Survivin and Aurora B kinase, two interesting targets for cancer therapy

✍ Scribed by A. Molla; M. Delacour-Larose; A. Valette; S. Dimitrov

Book ID: 119598541
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 99 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)71312-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aurora kinases as targets for cancer the

Aurora kinases as targets for cancer therapy

✍ Giannis Mountzios; Evangelos Terpos; Meletios-Athanassios Dimopoulos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Aurora Kinases: New Targets for Cancer T

Aurora Kinases: New Targets for Cancer Therapy

✍ Carvajal, R. D.; Tse, A.; Schwartz, G. K. 📂 Article 📅 2006 🏛 American Association for Cancer Research 🌐 English ⚖ 268 KB

Biology of Aurora A kinase: Implications

Biology of Aurora A kinase: Implications in cancer manifestation and therapy

✍ Dhanasekaran Karthigeyan; Sallekoppal B. Benaka Prasad; Jayasha Shandilya; Shipr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

The Aurora A kinase belongs to serine/threonine group of kinases, well known for its role in cell cycle, especially in the regulation of mitosis. Numerous substrates of Aurora A kinase have been identified, which are predominantly related to cell cycle progression while some of them are transcriptio

Downregulation of survivin and aurora A

Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: A new drug combination for cancer therapy

✍ Anat Biran; Michael Brownstein; Ronit Haklai; Yoel Kloog 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 892 KB

## Abstract Histone deacetylase (HDAC) inhibitors, such as valproic acid (VPA), constitute a novel class of anticancer agents that cause an increase in acetylated histones and thus restore the expression of dormant tumor‐suppressor and other genes related to cell differentiation, cell‐cycle arrest

Multifaceted polo-like kinases: drug tar

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

✍ Strebhardt, Klaus 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 912 KB

Aurora kinase A inhibition and paclitaxe

Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma

✍ Abhijit Mazumdar; Ying C. Henderson; Adel K. El-Naggar; Subrata Sen; Gary L. Cla 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

## Abstract ## Background. Aurora kinase A (AURKA) is amplified with varying incidence in multiple human cancers including head and neck squamous cell carcinoma (HNSCC). We investigated whether AURKA is a potential therapeutic target in HNSCC. ## Methods. We conducted an immunohistochemical anal